144
0001967150
XXXXXXXX
LIVE
0001672619
Enliven Therapeutics, Inc.
001-39247
6200 LOOKOUT ROAD
BOULDER
CO
80301
720-647-8519
Lyssikatos Joseph P
Officer
Common
Jefferies LLC
520 Madison Ave
4th Fl
New York
NY
10022
25000
914750.00
59000000
03/31/2026
Nasdaq
Common
09/01/2019
Founder Shares
Enliven Therapeutics
N
25000
09/01/2019
N/A
N
Joseph Lyssikatos
6200 Lookout Rd
1st Fl
Boulder
CO
80301
Enliven Therapeutics Inc
01/08/2026
41302
993437.48
Joseph Lyssikatos
6200 Lookout Rd
1st Fl
Boulder
CO
80301
Enliven Therapeutics Inc
01/09/2026
91198
2482579.19
Joseph Lyssikatos
6200 Lookout Rd
1st Fl
Boulder
CO
80301
Enliven Therapeutics Inc
01/20/2026
20000
535099.00
Joseph Lyssikatos
6200 Lookout Rd
1st Fl
Boulder
CO
80301
Enliven Therapeutics Inc
02/06/2026
5000
145219.10
Joseph Lyssikatos
6200 Lookout Rd
1st Fl
Boulder
CO
80301
Enliven Therapeutics Inc
02/18/2026
50000
1317640.00
Joseph Lyssikatos
6200 Lookout Rd
1st Fl
Boulder
CO
80301
Enliven Therapeutics Inc
02/19/2026
20000
520217.41
Joseph Lyssikatos
6200 Lookout Rd
1st Fl
Boulder
CO
80301
Enliven Therapeutics Inc
02/25/2026
5000
144613.70
All sales are to be made pursuant to a previously signed/adopted 10b5-1 selling plan dated 12/30/2025, and all representations regarding material non-public information were made as of the adoption of the plan. The shares in this filing will be sold from The Lyssikatos Revocable Trust UAD 12/15/11.
03/31/2026
12/30/2025
Joseph Lyssikatos